-
Heron's Non-Opioid, Post-Operative Pain Drug Approved By FDA: Why This Is Important
Thursday, May 13, 2021 - 11:01am | 668Read More...Shares of Heron Therapeutics Inc (NASDAQ: HRTX) are higher after a long wait to get regulatory approval for its non-opioid pain drug. What Happened: San Diego, California-based Heron, a commercial-stage biotechnology company focused on developing treatments for unmet patient...
